Bristol Myers' $1.5B buyout of Orbital Therapeutics expands its cell therapy reach with a next-gen in vivo CAR T candidate and advanced RNA platform.

Bristol Myers' $1.5B buyout of Orbital Therapeutics expands its cell therapy reach with a next-gen in vivo CAR T candidate and advanced RNA platform.

SHW expands its Latin American footprint with the acquisition of BASF's Brazilian paint brand Suvinil, boosting growth and scale in the region.

SHW expands its Latin American footprint with the acquisition of BASF's Brazilian paint brand Suvinil, boosting growth and scale in the region.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The $600 million transaction expands Boluda Towage’s presence to five continents and strengthens its fleet with 39 additional tugs. In total, it...

TDG expands its product offering with a $765 million cash buyout of Simmonds Precision Products from RTX.

Pentair (PNR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Pentair (PNR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Acquisition strengthens Fertiglobe’s downstream presence and advances its Asia-Pacific growth strategy.